Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sickle Cell Gene Therapy Makers Would Pay For Fertility Services In Medicaid Payment Model

Mar 19 2024

• By Cathy Kelly

• Source: Shutterstock

Related Content

Medicaid Payment Model For Sickle Cell Gene Therapy May Have Limited Impact Until 2026

Feb 27 2024

Sickle Cell Gene Therapy In Medicaid: CMMI Model As ‘Bandwidth Extender’ For Less Resourced States

Feb 01 2024

Related Companies

Vertex Pharmaceuticals Incorporated

Bluebird Bio

Additional Topics

United States Reimbursement Medicaid Gene Therapy Policy Blood & Coagulation Disorders BioPharmaceutical

More from Market Access

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.